Optical Coherence Tomography in the Diagnosis of Scleritis and Episcleritis
NCT ID: NCT01958567
Last Updated: 2014-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2012-07-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.
NCT02849093
Optical Coherence Tomography (OCT) in Retinal Vasculitis
NCT01998464
Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography
NCT01946997
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
NCT01746537
Objective Choroidal Thickness Measurements in Uveitis
NCT03889860
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with clinical signs of scleritis or episcleritis
Optical Coherence Tomography for patients with scleral inflammation
Optical Coherence Tomography
Normal subjects with normal sclera
Optical Coherence Tomography on eyes with normal scleral
Optical Coherence Tomography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical Coherence Tomography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with clinical signs of scleritis or episcleritis
* Signed informed consent
Exclusion Criteria
* Patients 18 years or younger
* Inability to open the eye
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Eye Center and The Eye Foundation for Research in Ophthalmology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samir S. Shoughy, MD, FRCS (Glasg.)
Ophthalmologist
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Eye Center
Riyadh, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEC 2013-006 [THE EYE CENTER]
Identifier Type: -
Identifier Source: secondary_id
TEC 125
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.